Grand River Health Care | |
118 Trenton Road, Chillicothe, Missouri 64601 | |
(660) 646-0353 | |
Name | Grand River Health Care |
---|---|
Location | 118 Trenton Road, Chillicothe, Missouri |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 60 |
Occupancy Rate | 59.67% |
Medicare ID (CCN) | 265480 |
Legal Business Name | N & R Of Chillicothe, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1124014436 |
Organization Name | N & R OF CHILLICOTHE, INC. |
Doing Business As | GRAND RIVER HEALTH CARE |
Address | 118 Trenton Rd, Chillicothe, MO 64601 |
Phone Number | 660-646-0353 |
News Archive
Sistemic today announced immediate availability new SistemRNA product lines in key therapeutic areas including oncology and inflammation. These new product additions will strengthen strategic decision making at critical stages of the drug discovery and development process, helping to realise the full value of client's compound assets.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
Hendra virus is a bat-borne virus that has killed four of the seven humans who have been infected and caused the deaths more than 40 horses since it was discovered in 1994. Humans contract the disease from horses but there has been neither human-to-human transmission of the disease nor direct transmission from bats to humans report experts. The majority of outbreaks have occurred during June and October, however last year a horse in Tewantin contracted the virus in May.
Unigene Laboratories, Inc. announced today that Novartis and its license partner Nordic Bioscience have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E. coli manufacturing technology.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Sistemic today announced immediate availability new SistemRNA product lines in key therapeutic areas including oncology and inflammation. These new product additions will strengthen strategic decision making at critical stages of the drug discovery and development process, helping to realise the full value of client's compound assets.
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
Hendra virus is a bat-borne virus that has killed four of the seven humans who have been infected and caused the deaths more than 40 horses since it was discovered in 1994. Humans contract the disease from horses but there has been neither human-to-human transmission of the disease nor direct transmission from bats to humans report experts. The majority of outbreaks have occurred during June and October, however last year a horse in Tewantin contracted the virus in May.
Unigene Laboratories, Inc. announced today that Novartis and its license partner Nordic Bioscience have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E. coli manufacturing technology.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $23264 |
Number of Payment Denials | 2 |
Total Number of Penalties | 4 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.39 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.1 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 18.81 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.88 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.79 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.49 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.01 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 71.11 | 14.2 |